IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
D000818:Animals; D000970:Antineoplastic Agents; D001152:Arsenicals; D002219:Carbamates; D002277:Carcinoma; D002286:Carcinoma, Ehrlich Tumor; D003078:Colchicine; D003609:Dactinomycin; D004054:Diethylstilbestrol; D004791:Enzyme Inhibitors; D005472:Fluorouracil; D006854:Hydrocortisone; D066298:In Vitro Techniques; D008466:Mechlorethamine; D015122:Mercaptopurine; D008727:Methotrexate; D051379:Mice; D010088:Oxidoreductases; D012106:Research; D013792:Thalidomide; D013852:Thiotepa
D000970:Antineoplastic Agents; D001152:Arsenicals; D002219:Carbamates; D004791:Enzyme Inhibitors; D003609:Dactinomycin; D013792:Thalidomide; D008466:Mechlorethamine; D004054:Diethylstilbestrol; D013852:Thiotepa; D015122:Mercaptopurine; D010088:Oxidoreductases; D003078:Colchicine; D005472:Fluorouracil; D006854:Hydrocortisone; D008727:Methotrexate
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; ARSENICALS; CARBAMATES; CARCINOMA, EHRLICH TUMOR; COLCHICINE; DIETHYLSTILBESTROL; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FLUOROURACIL; HYDROCORTISONE; MECHLORETHAMINE; MERCAPTOPURINE; METHOTREXATE; MICE; THALIDOMIDE; THIO-TEPA